Recent Searches

You haven't searched anything yet.

1 ScientistI/Scientist II, Biology (Must Have Small Molecule Drug Discovery Experience) Job in San Francisco, CA

SET JOB ALERT
Details...
ScientistI/Scientist II, Biology (Must Have Small Molecule Drug Discovery Experience)
Scorpion Therapeutics San Francisco, CA
$72k-94k (estimate)
Full Time | Business Services 2 Months Ago
Save

Scorpion Therapeutics is Hiring a ScientistI/Scientist II, Biology (Must Have Small Molecule Drug Discovery Experience) Near San Francisco, CA

We are seeking a highly motivated cancer biologist to join our Target Biology team in South San Francisco. The successful candidate will play a key role in target ID/validation efforts and accelerating drug discovery by developing/implementing a variety of cell-based assays to elucidate target function and enable small molecule screening efforts. They will deeply explore the target biology to refine indication space and/or biomarker hypotheses, mechanistically “connect the dots” from target engagement to phenotype in disease-relevant contexts, and ideally will bring in-depth knowledge of transcription factor biology including mechanisms of regulation, interaction with transcriptional machinery and dynamics of DNA binding. As a core member of the biology group, they will collaborate closely with other functional groups to drive project momentum and communicate key biology updates cross-functionally.

KEY RESPONSIBILITIES

  • Design and execute experiments to evaluate novel precision oncology targets and elucidate mechanisms of transcription factor regulation using genetic and pharmacological approaches.
  • Design, optimize, and implement robust cell-based assays to characterize drug/target MoA and to enable a robust screening funnel.
  • Collect, process, analyze, and summarize data for presentations, reports, publications, and patents.
  • Keep up to date with the latest scientific advances in technologies and trends in oncology research and development, and contribute to group strategy.
  • Mentor and direct junior lab members.
  • Maintain excellent communication across internal and external team members.

PROFESSIONAL EXPERIENCE/QUALIFICATIONS

  • Ph.D. in cancer biology or closely related field with 2-6 years of additional experience in oncology discovery (ideally industry); BS/MS with 10-14 years industry experience (ideally small molecule drug discovery).
  • Must have experience in cell-based assay development and execution across different cellular assay formats to enable small molecule drug discovery/characterization, ideally with some emphasis on transcriptional readouts (qPCR, luciferase-based reporters, CUT&RUN, CUT&Tag, ChIP-seq, HTFR, BRET, ALPHA screen, ELISA, Protein Simple, western, etc.).
  • Broad technical experience sufficient to design and execute target validation and MoA studies (CRISPR KO/KI, genetic rescue, general molecular biology, etc.).
  • Demonstrated ability to independently and consistently drive projects from concept/hypothesis through major milestones (pipeline advancement or impactful publication)
  • Exceptional scientific rigor and commitment to the highest-quality research with outstanding organizational abilities and scientific execution.
  • A highly engaged and motivated self-starter who is creative, innovative, communicative and possesses both a collaborative and goal/results-orientated style.
  • Desire to work in a fast-paced, multi-tasking environment, while employing tact, patience, diplomacy and a collaborative spirit.
  • Outstanding decision making, organizational and analytical skills.
  • Excellent interpersonal and communication skills.

Job Summary

JOB TYPE

Full Time

INDUSTRY

Business Services

SALARY

$72k-94k (estimate)

POST DATE

03/10/2024

EXPIRATION DATE

07/10/2024

WEBSITE

scorpiontx.com

HEADQUARTERS

BOSTON, MA

SIZE

25 - 50

FOUNDED

2020

TYPE

Private

CEO

CLAUDIO NESSI

REVENUE

<$5M

INDUSTRY

Business Services

Related Companies
About Scorpion Therapeutics

Scorpion Therapeutics is a pharmaceutical firm that researches and commercializes therapeutics for the treatment of oncology.

Show more